Study: NCT02652442

Adverse event: Symptom of Nausea
Serious: no
Organ System: General disorders
Notes: Any increase in symptom (nausea) severity \> 0.2 measured using a visual analog scale (Range: 0-10) was included as an adverse event.
Frequency: 1 affected / 6 at risk

Adverse event: Symptom of Disorientation
Serious: no
Organ System: General disorders
Notes: Any increase in symptom (disorientation) severity \> 0.2 measured using a visual analog scale (Range: 0-10) was included as an adverse event.
Frequency: 6 affected / 6 at risk

Adverse event: Symptom of Anxiety
Serious: no
Organ System: General disorders
Notes: Any increase in symptom (anxiety) severity \> 0.2 measured using a visual analog scale (Range: 0-10) was included as an adverse event.
Frequency: 1 affected / 6 at risk

Adverse event: Symptom of Dizziness
Serious: no
Organ System: General disorders
Notes: Any increase in symptom (dizziness) severity \> 0.2 measured using a visual analog scale (Range: 0-10) was included as an adverse event.
Frequency: 4 affected / 6 at risk

Adverse event: Symptom of Unsteadiness
Serious: no
Organ System: General disorders
Notes: Any increase in symptom (unsteadiness) severity \> 0.2 measured using a visual analog scale (Range: 0-10) was included as an adverse event.
Frequency: 4 affected / 6 at risk

Adverse event: Symptom of Nausea
Serious: no
Organ System: General disorders
Notes: Any increase in symptom (nausea) severity \> 0.2 measured using a visual analog scale (Range: 0-10) was included as an adverse event.
Frequency: 3 affected / 5 at risk

Adverse event: Symptom of Disorientation
Serious: no
Organ System: General disorders
Notes: Any increase in symptom (disorientation) severity \> 0.2 measured using a visual analog scale (Range: 0-10) was included as an adverse event.
Frequency: 4 affected / 5 at risk

Adverse event: Symptom of Anxiety
Serious: no
Organ System: General disorders
Notes: Any increase in symptom (anxiety) severity \> 0.2 measured using a visual analog scale (Range: 0-10) was included as an adverse event.
Frequency: 2 affected / 5 at risk

Adverse event: Symptom of Dizziness
Serious: no
Organ System: General disorders
Notes: Any increase in symptom (dizziness) severity \> 0.2 measured using a visual analog scale (Range: 0-10) was included as an adverse event.
Frequency: 2 affected / 5 at risk

Adverse event: Symptom of Unsteadiness
Serious: no
Organ System: General disorders
Notes: Any increase in symptom (unsteadiness) severity \> 0.2 measured using a visual analog scale (Range: 0-10) was included as an adverse event.
Frequency: 3 affected / 5 at risk

Adverse event: Symptom of Nausea
Serious: no
Organ System: General disorders
Notes: Any increase in symptom (nausea) severity \> 0.2 measured using a visual analog scale (Range: 0-10) was included as an adverse event.
Frequency: 3 affected / 5 at risk

Adverse event: Symptom of Disorientation
Serious: no
Organ System: General disorders
Notes: Any increase in symptom (disorientation) severity \> 0.2 measured using a visual analog scale (Range: 0-10) was included as an adverse event.
Frequency: 4 affected / 5 at risk

Adverse event: Symptom of Anxiety
Serious: no
Organ System: General disorders
Notes: Any increase in symptom (anxiety) severity \> 0.2 measured using a visual analog scale (Range: 0-10) was included as an adverse event.
Frequency: 3 affected / 5 at risk

Adverse event: Symptom of Dizziness
Serious: no
Organ System: General disorders
Notes: Any increase in symptom (dizziness) severity \> 0.2 measured using a visual analog scale (Range: 0-10) was included as an adverse event.
Frequency: 3 affected / 5 at risk

Adverse event: Symptom of Unsteadiness
Serious: no
Organ System: General disorders
Notes: Any increase in symptom (unsteadiness) severity \> 0.2 measured using a visual analog scale (Range: 0-10) was included as an adverse event.
Frequency: 2 affected / 5 at risk

Adverse event: Symptom of Nausea
Serious: no
Organ System: General disorders
Notes: Any increase in symptom (nausea) severity \> 0.2 measured using a visual analog scale (Range: 0-10) was included as an adverse event.
Frequency: 2 affected / 5 at risk

Adverse event: Symptom of Disorientation
Serious: no
Organ System: General disorders
Notes: Any increase in symptom (disorientation) severity \> 0.2 measured using a visual analog scale (Range: 0-10) was included as an adverse event.
Frequency: 4 affected / 5 at risk

Adverse event: Symptom of Anxiety
Serious: no
Organ System: General disorders
Notes: Any increase in symptom (anxiety) severity \> 0.2 measured using a visual analog scale (Range: 0-10) was included as an adverse event.
Frequency: 1 affected / 5 at risk

Adverse event: Symptom of Dizziness
Serious: no
Organ System: General disorders
Notes: Any increase in symptom (dizziness) severity \> 0.2 measured using a visual analog scale (Range: 0-10) was included as an adverse event.
Frequency: 1 affected / 5 at risk

Adverse event: Symptom of Unsteadiness
Serious: no
Organ System: General disorders
Notes: Any increase in symptom (unsteadiness) severity \> 0.2 measured using a visual analog scale (Range: 0-10) was included as an adverse event.
Frequency: 1 affected / 5 at risk